Exscientia Announces EUR250 Million Collaboration for a Multiple-Product Development and Licence Option Agreement with Sanofi

Corporate Breaking News

Home : Exscientia Announces EUR250 Million Collaboration for a Multiple-Product Development and Licence Option Agreement with Sanofi

May 09 2017	Exscientia Announces EUR250 Million Collaboration for a Multiple-Product Development and Licence Option Agreement with Sanofi
DUNDEE, Scotland, May 9, 2017 /PRNewswire/ -- Initiates collaboration to develop bispecific-small-molecule drugs Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce that it has agreed a strategic...


Source:http://www.prnewswire.com/news-releases/exscientia-announces-eur250-million-collaboration-for-a-multiple-product-development-and-licence-option-agreement-with-sanofi-621706173.html

Related News
» Frost & Sullivan Lauds Lifesize's Strategic Shift from On-premises to Cloud-based Video Services for the EMEA Video Conferencing Market » PGi Selects BillingPlatform to Transform Their Billing and Monetization Capabilities